Clinical trial · Interventional
SW-IMRT Versus ST-IMRT in the Treatment of Head and Neck Cancer
Swallowing Sparing IMRT (SW-IMRT) Versus Standard Parotid Sparing IMRT (ST-IMRT) in the Treatment of Head and Neck Cancer
NCT04597177CI-TRIAL-00053962unknownN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
To clinically validate whether SW-IMRT actually reduce the occurrence of swallowing dysfunction as compared to ST-IMRT.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Swallowing Dysfunction | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| ST-IMRT SW-IMRT | Radiation | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- ACTIVE_COMPARATOR
- label
- ST-IMRT
- description
- standard parotid sparing IMRT
- interventionNames
- Radiation: ST-IMRT SW-IMRT
- type
- EXPERIMENTAL
- label
- SW-IMRT
- description
- swallowing sparing IMRT
- interventionNames
- Radiation: ST-IMRT SW-IMRT
Primary outcomes (2)
- measure
- Subjective assessment of the swallowing function (dysphagia) at regular intervals
- timeFrame
- 6 months
- description
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Patients with squamous cell carcinoma and requiring whole neck irradiation as a part of either definitive RT alone or in combination with chemotherapy or post-operative RT either alone or in combination with chemotherapy. Exclusion Criteria: * Previous radiotherapy to the head and neck region or prior malignancies, and/or distant metastases.
References
Publications (0)
Data not yet available
No reference posted for this study.